Currently, the primary treatment for celiac disease (CD) is a strict and lifelong gluten-free diet, which can saddle patients with heavy financial and social burdens. On top of this, many patients continue to get exposed to gluten accidentally, preventing their intestines from healing properly. Other forms of treatment, such as Alvine Pharmaceutical’s ALV003, are being […]
In the past, celiac disease (CD) was thought of as a children’s malabsorptive disease, but CD patients can experience many non-gastrointestinal symptoms, and a recent paper from Italy attempted to review how CD can affect the reproductive health of women.
The risk for certain types of malignancy in celiac disease (CD) patients has long been a cause for concern. Other types of cancers, such as breast cancer and lung cancer, may be less common in subjects with CD. Studies in the US and UK have pegged the overall increase in risk for malignancy at about […]
A recent study out of Finland investigated how a gluten-free diet, the treatment for CD, helps these asymptomatic patients who have no symptoms to tell them if their treatment is working.
The University of Chicago Celiac Disease Center has been investigating the mechanisms through which viral infections, in particular gastrointestinal viruses, can contribute to the inflammatory response occurring in celiac disease.
After diagnosis, celiac disease (CD) patients must get regular check ups to see if they are responding to their gluten-free diet. Up to 30% of patients have non-responsive celiac disease (NRCD), typically due to accidental gluten exposure. To see if a patient is recovering from CD the doctor can look for any lessening in symptoms, […]
While the prevalence of celiac disease is estimated to be about 1% in the United States, the number of people who have adopted a gluten-free diet is far greater, as shown by the rapidly expanding gluten-free market. For those people who feel better on a gluten-free diet but have tested negative for celiac disease and […]
Celiac disease, typically thought of as a gastrointestinal disease, has a wide variety of symptoms that can affect other parts of the body including the mind. Many people with celiac disease report having “brain fog”, a form of cognitive impairment that can encompass disorientation, problems with staying focused and paying attention, and lapses in short-term […]
The rate of celiac disease prevalence has been steadily rising. According to a study comparing the stored blood of soldiers with people today, it has increased up to four times within the past 50 years. Looking for the reason behind such a significant rise, many papers have been published investigating possible environmental causes, including one that found a link between celiac disease and an absence of H. pylori in the stomach. Another paper, involving three of the same doctors, including Celiac Disease Foundation’s own Medical Advisory Board Member Dr. Peter Green, found another possible explanation.
A recent study, published by The American Journal of Gastroenterology has uncovered a new potential method for treating celiac disease. The study, titled “Novel Role of the Serine Protease Inhibitor Elafin in Gluten-Related Disorders” was first published online on April 8th, 2014. It’s authors, doctors and scientists hailing from all over the world, looked at several different aspects of a protein called elafin and its effect on gluten-related disorders like celiac disease.